# RWO-06H Injection Master Validity Readonly Evidence

RUN_ID: `20260426T140206Z`

## Verdict

`RWO06H_READONLY_MASTER_VALIDITY_NOT_VALIDATED_STOP_BEFORE_LIVE`

The active rollback / owner-decision handoff remains pending because no new operator rollback rehearsal evidence and no explicit final owner GO/NO-GO/PENDING input was present in the repo. This run carried that blocker forward without reclassification and advanced the executable queue.

No live ORCA Trial mutation was executed.

## Scope

- Branch / start HEAD: `master` / `08b86278782aa10ddf9d40eb722d522aff5334af`
- Active prompt: `docs/implementation/automation-handoff/NEXT_WORKER_PROMPT.md`
- Current Work Order: `RWO-06H`
- Batched no-live Work Order: `RWO-06G`
- Injection endpoint identity: `/api/orca/official/chart-support/medical-mod-v2` / `medicalmodv2`
- Target identity: `00001`
- Injection payload: `web-client/qa/payloads/phase4/medicalmodv2_injection_trial_reachability_v2.json`
- Injection payload SHA-256: `1af0b23246e8f9ee79879b28a09888ecc719ec8f6381e2b798cd63fa020e3300`
- Base-charge payload SHA-256: `4c092e032dd6f56eb5542ad65b2b6b28a8e1c1c802900f83e795dbbdba7a403a`

## Threat Model / Misuse Cases

| Misuse case | Control | Result |
|---|---|---|
| Read-only master checks are promoted to `medicalmodv2` business acceptance. | Evidence classifies read-only validation separately and records `liveTrialMutation=not_run`. | Mitigated. |
| A failed medication master check is ignored and injection live mutation proceeds. | Summary sets `readonly_master_validity_not_validated_stop_before_live`. | Mitigated. |
| Raw ORCA XML, credentials, patient/insurance detail, or diagnostic artifacts are committed. | Wrapper writes only status classes, booleans, hashes, endpoint names, and code identities. | Mitigated. |
| Production ORCA or object storage is pulled into the preflight path. | Wrapper allowlists WebORCA Trial host only and uses no S3/object-storage configuration. | Mitigated. |

## Readonly Result

| Role | Endpoint | Code | Sanitized result |
|---|---|---|---|
| medication | `medicationgetv2` | `620000012` | `2xx` / `other_present` / `masterFound=false` |
| procedure | `masterlastupdatev3` | `130000510` | `2xx` / `success_zero` / `masterFound=true` |
| material | `masterlastupdatev3` | `700000031` | `2xx` / `success_zero` / `masterFound=true` |
| comment | `masterlastupdatev3` | `0085001` | `2xx` / `success_zero` / `masterFound=true` |

Because the medication row was not validated, `injectionOrder/310` is not ready for a live Trial mutation.

## RWO-06G Same-Run Progress

The next queue item, `RWO-06G_NO_LIVE_FIRST_VISIT_PLAN`, was prepared as sanitized no-live evidence:

- [base-charge-first-visit-plan.sanitized.json](base-charge-first-visit-plan.sanitized.json)

This plan requires a future `acceptmodv2` `Request_Number=00` read-only first-visit compatibility check before any baseChargeOrder/110 live Trial attempt. It is not business success evidence.

## Verification

| Check | Result |
|---|---|
| `node --check web-client/scripts/qa-lib/phase4-master-validity-evidence.mjs && node --check web-client/scripts/qa-phase4-injection-master-validity.mjs` | PASS |
| `npm --prefix web-client test -- --run scripts/__tests__/phase4MasterValidityEvidence.test.ts` | PASS; 6 tests; web guard pretest passed |
| `npm --prefix web-client test -- --run scripts/__tests__/phase4MasterValidityEvidence.test.ts scripts/__tests__/phase4Medicalmodv2SafeEvidence.test.ts` | PASS; 30 tests; web guard pretest passed |
| `npm --prefix web-client run verify:web-guard` | PASS |
| `bash server-modernized/tools/ci/check-doc-links.sh` | PASS |
| Focused sensitive-pattern scan over new evidence/wrapper files | PASS with expected code/test-fixture hits only |
| `qa-phase4-injection-master-validity.mjs --dry-run` | PASS; no ORCA network action |
| `qa-phase4-injection-master-validity.mjs --execute-readonly` | Expected stop before live; read-only evidence recorded |

## Evidence

- [summary.sanitized.json](summary.sanitized.json)
- [command-log.jsonl](command-log.jsonl)
- [dry-run/master-validity-readonly-summary.sanitized.json](dry-run/master-validity-readonly-summary.sanitized.json)
- [read-only/master-validity-readonly-summary.sanitized.json](read-only/master-validity-readonly-summary.sanitized.json)
- [base-charge-first-visit-plan.sanitized.json](base-charge-first-visit-plan.sanitized.json)

## Claim Boundary

Allowed claim: `RWO-06H` now has a sanitized Trial read-only master-validity attempt and stops before live because the medication row was not validated; `RWO-06G` now has a no-live first-visit compatibility plan.

Not claimed: injection Trial business acceptance, base-charge Trial business acceptance, any live mutation in this run, broad all-order readiness, fullflow/L4 success, actual rollback rehearsal, final owner GO/NO-GO, production ORCA readiness, S3/object-storage readiness, attachment/PHR storage readiness, or final release readiness.

## Security Notes

- Credentials printed or captured: `false`
- Raw ORCA request/response bodies captured: `false`
- Raw patient/insurance detail captured: `false`
- Diagnostic artifacts captured: `false`
- Raw artifacts committed or packaged: `false`
- Production ORCA attempted: `false`
- S3/MinIO/object-storage configuration requested or used: `false`

## Recommended Next Action

Run the RWO-06G `acceptmodv2` `Request_Number=00` read-only first-visit compatibility check for `baseChargeOrder/110` v2. Do not run the injection live mutation unless medication row validity has changed evidence or a changed injection candidate identity is prepared.
